Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Connected Injectable Drug Delivery Devices Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Connected Injectable Drug Delivery Devices Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Conventional
      • 1.3.3 Self-Injection
      • 1.3.4 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Connected Injectable Drug Delivery Devices Market Share by Application (2019-2025)
      • 1.4.2 Diabetes
      • 1.4.3 Cardiovascular Diseases
      • 1.4.4 Autoimmune Diseases
      • 1.4.5 Hormones Replacement
      • 1.4.6 Neurology
      • 1.4.7 Addiction
      • 1.4.8 Respiratory Diseases
      • 1.4.9 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Connected Injectable Drug Delivery Devices Production Value 2014-2025
      • 2.1.2 Global Connected Injectable Drug Delivery Devices Production 2014-2025
      • 2.1.3 Global Connected Injectable Drug Delivery Devices Capacity 2014-2025
      • 2.1.4 Global Connected Injectable Drug Delivery Devices Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Connected Injectable Drug Delivery Devices Market Size CAGR of Key Regions
      • 2.2.2 Global Connected Injectable Drug Delivery Devices Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Connected Injectable Drug Delivery Devices Capacity by Manufacturers
      • 3.1.2 Global Connected Injectable Drug Delivery Devices Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Connected Injectable Drug Delivery Devices Revenue by Manufacturers (2014-2019)
      • 3.2.2 Connected Injectable Drug Delivery Devices Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Connected Injectable Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
    • 3.3 Connected Injectable Drug Delivery Devices Price by Manufacturers
    • 3.4 Key Manufacturers Connected Injectable Drug Delivery Devices Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Connected Injectable Drug Delivery Devices Market
    • 3.6 Key Manufacturers Connected Injectable Drug Delivery Devices Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Conventional Production and Production Value (2014-2019)
      • 4.1.2 Self-Injection Production and Production Value (2014-2019)
      • 4.1.3 Others Production and Production Value (2014-2019)
    • 4.2 Global Connected Injectable Drug Delivery Devices Production Market Share by Type
    • 4.3 Global Connected Injectable Drug Delivery Devices Production Value Market Share by Type
    • 4.4 Connected Injectable Drug Delivery Devices Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Connected Injectable Drug Delivery Devices Consumption by Application

    6 Production by Regions

    • 6.1 Global Connected Injectable Drug Delivery Devices Production (History Data) by Regions 2014-2019
    • 6.2 Global Connected Injectable Drug Delivery Devices Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Connected Injectable Drug Delivery Devices Production Growth Rate 2014-2019
      • 6.3.2 United States Connected Injectable Drug Delivery Devices Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Connected Injectable Drug Delivery Devices Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Connected Injectable Drug Delivery Devices Production Growth Rate 2014-2019
      • 6.4.2 European Union Connected Injectable Drug Delivery Devices Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Connected Injectable Drug Delivery Devices Import & Export
    • 6.5 China
      • 6.5.1 China Connected Injectable Drug Delivery Devices Production Growth Rate 2014-2019
      • 6.5.2 China Connected Injectable Drug Delivery Devices Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Connected Injectable Drug Delivery Devices Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Connected Injectable Drug Delivery Devices Consumption by Regions

    • 7.1 Global Connected Injectable Drug Delivery Devices Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Connected Injectable Drug Delivery Devices Consumption by Type
      • 7.2.2 United States Connected Injectable Drug Delivery Devices Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Connected Injectable Drug Delivery Devices Consumption by Type
      • 7.3.2 European Union Connected Injectable Drug Delivery Devices Consumption by Application
    • 7.4 China
      • 7.4.1 China Connected Injectable Drug Delivery Devices Consumption by Type
      • 7.4.2 China Connected Injectable Drug Delivery Devices Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Connected Injectable Drug Delivery Devices Consumption by Type
      • 7.5.2 Rest of World Connected Injectable Drug Delivery Devices Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Phillips-Medisize
      • 8.1.1 Phillips-Medisize Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Connected Injectable Drug Delivery Devices
      • 8.1.4 Connected Injectable Drug Delivery Devices Product Introduction
      • 8.1.5 Phillips-Medisize Recent Development
    • 8.2 West Pharmaceutical Services
      • 8.2.1 West Pharmaceutical Services Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Connected Injectable Drug Delivery Devices
      • 8.2.4 Connected Injectable Drug Delivery Devices Product Introduction
      • 8.2.5 West Pharmaceutical Services Recent Development
    • 8.3 Biocorp
      • 8.3.1 Biocorp Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Connected Injectable Drug Delivery Devices
      • 8.3.4 Connected Injectable Drug Delivery Devices Product Introduction
      • 8.3.5 Biocorp Recent Development
    • 8.4 Aterica
      • 8.4.1 Aterica Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Connected Injectable Drug Delivery Devices
      • 8.4.4 Connected Injectable Drug Delivery Devices Product Introduction
      • 8.4.5 Aterica Recent Development
    • 8.5 Unilife
      • 8.5.1 Unilife Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Connected Injectable Drug Delivery Devices
      • 8.5.4 Connected Injectable Drug Delivery Devices Product Introduction
      • 8.5.5 Unilife Recent Development
    • 8.6 Propeller Health
      • 8.6.1 Propeller Health Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Connected Injectable Drug Delivery Devices
      • 8.6.4 Connected Injectable Drug Delivery Devices Product Introduction
      • 8.6.5 Propeller Health Recent Development
    • 8.7 Haselmeier
      • 8.7.1 Haselmeier Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Connected Injectable Drug Delivery Devices
      • 8.7.4 Connected Injectable Drug Delivery Devices Product Introduction
      • 8.7.5 Haselmeier Recent Development
    • 8.8 SHL
      • 8.8.1 SHL Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Connected Injectable Drug Delivery Devices
      • 8.8.4 Connected Injectable Drug Delivery Devices Product Introduction
      • 8.8.5 SHL Recent Development
    • 8.9 Becton Dickinson
      • 8.9.1 Becton Dickinson Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Connected Injectable Drug Delivery Devices
      • 8.9.4 Connected Injectable Drug Delivery Devices Product Introduction
      • 8.9.5 Becton Dickinson Recent Development
    • 8.10 Baxter International
      • 8.10.1 Baxter International Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Connected Injectable Drug Delivery Devices
      • 8.10.4 Connected Injectable Drug Delivery Devices Product Introduction
      • 8.10.5 Baxter International Recent Development
    • 8.11 Scandinavian Health
    • 8.12 Ypsomed
    • 8.13 Terumo Medical
    • 8.14 Schott
    • 8.15 Owen Mumford
    • 8.16 Antares Pharma
    • 8.17 Zogenix

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Connected Injectable Drug Delivery Devices Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Connected Injectable Drug Delivery Devices Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Connected Injectable Drug Delivery Devices Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Connected Injectable Drug Delivery Devices Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Connected Injectable Drug Delivery Devices Production Forecast by Type
      • 9.7.2 Global Connected Injectable Drug Delivery Devices Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Connected Injectable Drug Delivery Devices Sales Channels
      • 10.2.2 Connected Injectable Drug Delivery Devices Distributors
    • 10.3 Connected Injectable Drug Delivery Devices Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Connected injectable drug delivery devices reminds and records patients dosing pattern and makes it accessible to healthcare professionals for significant understanding about the patient condition.
      Growing prevalence of chronic diseases like diabetes, cardiovascular disease, and cancer coupled with increasing compliance to the treatment owing to use of the Connected injectable drug delivery devices.
      In 2019, the market size of Connected Injectable Drug Delivery Devices is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Connected Injectable Drug Delivery Devices.

      This report studies the global market size of Connected Injectable Drug Delivery Devices, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Connected Injectable Drug Delivery Devices production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Phillips-Medisize
      West Pharmaceutical Services
      Biocorp
      Aterica
      Unilife
      Propeller Health
      Haselmeier
      SHL
      Becton Dickinson
      Baxter International
      Scandinavian Health
      Ypsomed
      Terumo Medical
      Schott
      Owen Mumford
      Antares Pharma
      Zogenix

      Market Segment by Product Type
      Conventional
      Self-Injection
      Others

      Market Segment by Application
      Diabetes
      Cardiovascular Diseases
      Autoimmune Diseases
      Hormones Replacement
      Neurology
      Addiction
      Respiratory Diseases
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Connected Injectable Drug Delivery Devices status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Connected Injectable Drug Delivery Devices manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Connected Injectable Drug Delivery Devices are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now